Crowdonomics
This isn’t 20/20 GeneSystems’s most recent raise. Reg CF Offering (2025-10-30) (Closed) is more current.View latest round
20/20 GeneSystems

Reg A Offering (2018)

ClosedReg A+
via STARTENGINE PRIMARY LLC · last checked Sep 7, 2026
Raised
$0
Investors
Valuation

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

4 amendments
  1. Aug 14, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Aug 1, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Jul 11, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Jun 22, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target
Max
Min investment
OpenedMar 9, 2018
Deadline
ClosedAug 12, 2019
Days active521

Links & provenance

Source: SEC EDGAR
0001213900-18-002777
Last synced Sep 7, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.